Categories: Medicine, Science & Health Care
Travels from San Francisco, California, USA
Dr. Atul Butte is a biomedical research and biotechnology developer, top health and wellness keynote speaker, inventor, and author. Dr. Butte has been continually funded by NIH for 20 years and is an inventor on 24 patents.
Dr. Atul Butte has a focus on both biotechnology and investment. His experience with startups makes him unique in the healthcare space. Butte often gives technology speeches on how medicine and technology can work together to deliver superior results. Dr. Butte has been continually funded by NIH for 20 years, is an inventor on 24 patents, and has authored over 200 publications, with his research repeatedly featured in the New York Times, Wall Street Journal, and Wired Magazine. Dr. Butte was elected to the National Academy of Medicine in 2015, and in 2013, he was recognized by the Obama Administration as a White House Champion of Change in Open Science for promoting science through publicly available data.
Dr. Atul Butte, MD, Ph.D. is the Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire University of California Health System, with 18 health professional schools, 6 medical centers, 10 hospitals, and over 1,000 care delivery sites.
Dr. Atul Butte's awards include the 2010 Society for Pediatric Research Young Investigator Award, induction into the American College of Medical Informatics in 2009, the 2008 AMIA New Investigator Award, the 2007 Genome Technology “Tomorrow’s Principal Investigator” Award, the 2007 Society for Medical Decision Making Award for Outstanding Short Course, the 2006 Howard Hughes Medical Institute Early Career Award, the 2006 PhRMA Foundation Research Starter Grant in Informatics, and the 2002 and 2003 American Association for Clinical Chemistry Outstanding Speaker Award. Dr. Butte also co-authored one of the first books on microarray analysis titled “Microarrays For An Integrative Genomics” published by MIT Press.
Dr. Atul Butte is also a founder of three investor-backed data-driven companies: Personalis, providing medical genome sequencing services, Carmenta (acquired by Progenity), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. The Butte Laboratory builds and applies tools that convert more than 300 billion points of molecular, clinical, and epidemiological data into diagnostics, therapeutics, and new insights into diseases.
Dr. Atul Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children’s Hospital Boston, and received his Ph.D. from Harvard Medical School and MIT.
